US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist
  • 37.500
  • +0.970+2.66%
Close Sep 13 16:00 ET
  • 37.500
  • 0.0000.00%
Post 16:01 ET
1.21BMarket Cap14.10P/E (TTM)

Collegium Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-32.41%67.4M
123.83%61.94M
121.16%274.75M
10.57%73.34M
73.06%74.02M
146.53%99.72M
209.31%27.67M
19.96%124.23M
83.23%66.33M
147.88%42.77M
Net income from continuing operations
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
4,415.10%20.63M
350.57%13.01M
-33.34%-17.43M
-134.96%-25M
71.24%-7.2M
-94.32%457K
Operating gains losses
----
----
--23.5M
--0
--0
--0
--23.5M
----
----
----
Depreciation and amortization
-7.54%35.47M
-7.44%35.43M
7.43%149.26M
-17.73%35.46M
-2.33%37.15M
0.53%38.36M
94.94%38.28M
101.60%138.94M
150.33%43.1M
120.60%38.04M
Deferred tax
-452.36%-3.51M
-9,491.30%-4.41M
74.34%-2.15M
68.65%-338K
-154.03%-1.13M
81.14%-636K
99.24%-46K
89.25%-8.39M
92.82%-1.08M
656.23%2.1M
Other non cash items
-26.52%1.58M
-19.43%1.76M
-1.97%8.36M
-14.87%1.94M
-12.61%2.08M
-22.91%2.15M
103.73%2.18M
148.92%8.52M
193.44%2.28M
184.23%2.38M
Change In working capital
-105.56%-2.22M
77.41%-5.62M
270.94%21.73M
-108.93%-2.1M
258.18%8.83M
1,580.69%39.87M
24.78%-24.86M
-194.27%-12.71M
-55.85%23.55M
61.36%-5.58M
-Change in receivables
-178.66%-9.16M
21.01%4.83M
116.50%3.59M
-81.06%2.33M
-783.73%-14.37M
137.38%11.65M
179.76%3.99M
3.30%-21.78M
-71.54%12.28M
103.57%2.1M
-Change in inventory
-50.30%3.41M
-92.24%1.06M
-70.65%14.17M
-90.12%1.79M
-161.74%-8.1M
-58.81%6.87M
4,023.03%13.61M
2,202.53%48.27M
50,516.67%18.15M
486.10%13.12M
-Change in prepaid assets
-661.81%-11.51M
25.63%-177K
131.24%1.44M
124.93%1.4M
137.85%1.79M
-249.77%-1.51M
-135.16%-238K
-324.13%-4.61M
-141.97%-5.6M
-70.25%753K
-Change in payables and accrued expense
-34.20%15.04M
73.17%-11.33M
107.31%2.53M
-494.69%-7.62M
236.92%29.51M
32.28%22.86M
-45.33%-42.22M
-187.85%-34.6M
-110.22%-1.28M
-154.30%-21.55M
-Change in other working capital
----
----
----
----
----
----
----
--3K
--0
---1K
Cash from discontinued investing activities
Operating cash flow
-32.41%67.4M
123.83%61.94M
121.16%274.75M
10.57%73.34M
73.06%74.02M
146.53%99.72M
209.31%27.67M
19.96%124.23M
83.23%66.33M
147.88%42.77M
Investing cash flow
Cash flow from continuing investing activities
78.65%-8.91M
-10,200.00%-18.13M
87.66%-70.81M
-2,569.89%-25.1M
-3,282.30%-3.82M
-8,949.24%-41.72M
99.97%-176K
-29,410.85%-573.69M
-82.52%-940K
59.06%-113K
Net PPE purchase and sale
-382.14%-270K
-222.73%-568K
71.58%-461K
82.55%-164K
42.48%-65K
87.85%-56K
-62.96%-176K
16.56%-1.62M
-82.52%-940K
59.06%-113K
Net business purchase and sale
----
----
--0
--0
----
----
----
---572.07M
--0
--0
Net investment purchase and sale
79.27%-8.64M
---17.56M
---70.35M
---24.93M
---3.76M
---41.66M
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
78.65%-8.91M
-10,200.00%-18.13M
87.66%-70.81M
-2,569.89%-25.1M
-3,282.30%-3.82M
-8,949.24%-41.72M
99.97%-176K
-29,410.85%-573.69M
-82.52%-940K
59.06%-113K
Financing cash flow
Cash flow from continuing financing activities
-152.47%-114.21M
-179.28%-54.15M
-132.10%-140.18M
-162.66%-67.83M
-205.30%-95.41M
-88.75%-45.24M
-86.81%68.3M
589.04%436.72M
39.24%-25.82M
-17.90%-31.25M
Net issuance payments of debt
-70.86%-79.05M
-163.64%-45.83M
-114.89%-65.92M
-83.33%-45.83M
-83.34%-45.83M
-85.07%-46.27M
-86.09%72.02M
985.36%442.68M
-100.00%-25M
-100.00%-25M
Net common stock issuance
----
----
-433.31%-75M
-227.18%-25M
---50M
----
----
70.62%-14.06M
76.37%-7.64M
----
Proceeds from stock option exercised by employees
357.15%5.72M
13.54%4.56M
-25.08%9.1M
-52.79%3.24M
114.86%593K
-19.03%1.25M
15.96%4.02M
-4.40%12.15M
193.42%6.86M
-84.10%276K
Net other financing activities
-2,570.45%-5.88M
-66.42%-12.87M
-106.75%-8.36M
-417.78%-233K
-62.26%-172K
56.95%-220K
-128.74%-7.74M
2.53%-4.04M
---45K
51.82%-106K
Cash from discontinued financing activities
Financing cash flow
-152.47%-114.21M
-179.28%-54.15M
-132.10%-140.18M
-162.66%-67.83M
-205.30%-95.41M
-88.75%-45.24M
-86.81%68.3M
589.04%436.72M
39.24%-25.82M
-17.90%-31.25M
Net cash flow
Beginning cash position
-15.58%229.66M
36.18%239.99M
-6.74%176.24M
89.93%259.58M
127.35%284.8M
149.01%272.03M
-6.74%176.24M
6.97%188.97M
-30.19%136.67M
-38.99%125.27M
Current changes in cash
-536.34%-55.72M
-110.79%-10.34M
600.54%63.76M
-149.50%-19.59M
-321.12%-25.22M
-20.31%12.77M
220.15%95.79M
-203.48%-12.74M
680.51%39.56M
219.66%11.4M
End cash Position
-38.92%173.94M
-15.58%229.66M
36.18%239.99M
36.18%239.99M
89.93%259.58M
127.35%284.8M
149.01%272.03M
-6.74%176.24M
-6.74%176.24M
-30.19%136.67M
Free cash flow
-32.65%67.13M
123.20%61.37M
123.71%274.29M
11.91%73.17M
73.37%73.95M
149.23%99.67M
208.15%27.5M
20.66%122.61M
83.24%65.39M
151.24%42.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -32.41%67.4M123.83%61.94M121.16%274.75M10.57%73.34M73.06%74.02M146.53%99.72M209.31%27.67M19.96%124.23M83.23%66.33M147.88%42.77M
Net income from continuing operations 50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M4,415.10%20.63M350.57%13.01M-33.34%-17.43M-134.96%-25M71.24%-7.2M-94.32%457K
Operating gains losses ----------23.5M--0--0--0--23.5M------------
Depreciation and amortization -7.54%35.47M-7.44%35.43M7.43%149.26M-17.73%35.46M-2.33%37.15M0.53%38.36M94.94%38.28M101.60%138.94M150.33%43.1M120.60%38.04M
Deferred tax -452.36%-3.51M-9,491.30%-4.41M74.34%-2.15M68.65%-338K-154.03%-1.13M81.14%-636K99.24%-46K89.25%-8.39M92.82%-1.08M656.23%2.1M
Other non cash items -26.52%1.58M-19.43%1.76M-1.97%8.36M-14.87%1.94M-12.61%2.08M-22.91%2.15M103.73%2.18M148.92%8.52M193.44%2.28M184.23%2.38M
Change In working capital -105.56%-2.22M77.41%-5.62M270.94%21.73M-108.93%-2.1M258.18%8.83M1,580.69%39.87M24.78%-24.86M-194.27%-12.71M-55.85%23.55M61.36%-5.58M
-Change in receivables -178.66%-9.16M21.01%4.83M116.50%3.59M-81.06%2.33M-783.73%-14.37M137.38%11.65M179.76%3.99M3.30%-21.78M-71.54%12.28M103.57%2.1M
-Change in inventory -50.30%3.41M-92.24%1.06M-70.65%14.17M-90.12%1.79M-161.74%-8.1M-58.81%6.87M4,023.03%13.61M2,202.53%48.27M50,516.67%18.15M486.10%13.12M
-Change in prepaid assets -661.81%-11.51M25.63%-177K131.24%1.44M124.93%1.4M137.85%1.79M-249.77%-1.51M-135.16%-238K-324.13%-4.61M-141.97%-5.6M-70.25%753K
-Change in payables and accrued expense -34.20%15.04M73.17%-11.33M107.31%2.53M-494.69%-7.62M236.92%29.51M32.28%22.86M-45.33%-42.22M-187.85%-34.6M-110.22%-1.28M-154.30%-21.55M
-Change in other working capital ------------------------------3K--0---1K
Cash from discontinued investing activities
Operating cash flow -32.41%67.4M123.83%61.94M121.16%274.75M10.57%73.34M73.06%74.02M146.53%99.72M209.31%27.67M19.96%124.23M83.23%66.33M147.88%42.77M
Investing cash flow
Cash flow from continuing investing activities 78.65%-8.91M-10,200.00%-18.13M87.66%-70.81M-2,569.89%-25.1M-3,282.30%-3.82M-8,949.24%-41.72M99.97%-176K-29,410.85%-573.69M-82.52%-940K59.06%-113K
Net PPE purchase and sale -382.14%-270K-222.73%-568K71.58%-461K82.55%-164K42.48%-65K87.85%-56K-62.96%-176K16.56%-1.62M-82.52%-940K59.06%-113K
Net business purchase and sale ----------0--0---------------572.07M--0--0
Net investment purchase and sale 79.27%-8.64M---17.56M---70.35M---24.93M---3.76M---41.66M--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 78.65%-8.91M-10,200.00%-18.13M87.66%-70.81M-2,569.89%-25.1M-3,282.30%-3.82M-8,949.24%-41.72M99.97%-176K-29,410.85%-573.69M-82.52%-940K59.06%-113K
Financing cash flow
Cash flow from continuing financing activities -152.47%-114.21M-179.28%-54.15M-132.10%-140.18M-162.66%-67.83M-205.30%-95.41M-88.75%-45.24M-86.81%68.3M589.04%436.72M39.24%-25.82M-17.90%-31.25M
Net issuance payments of debt -70.86%-79.05M-163.64%-45.83M-114.89%-65.92M-83.33%-45.83M-83.34%-45.83M-85.07%-46.27M-86.09%72.02M985.36%442.68M-100.00%-25M-100.00%-25M
Net common stock issuance ---------433.31%-75M-227.18%-25M---50M--------70.62%-14.06M76.37%-7.64M----
Proceeds from stock option exercised by employees 357.15%5.72M13.54%4.56M-25.08%9.1M-52.79%3.24M114.86%593K-19.03%1.25M15.96%4.02M-4.40%12.15M193.42%6.86M-84.10%276K
Net other financing activities -2,570.45%-5.88M-66.42%-12.87M-106.75%-8.36M-417.78%-233K-62.26%-172K56.95%-220K-128.74%-7.74M2.53%-4.04M---45K51.82%-106K
Cash from discontinued financing activities
Financing cash flow -152.47%-114.21M-179.28%-54.15M-132.10%-140.18M-162.66%-67.83M-205.30%-95.41M-88.75%-45.24M-86.81%68.3M589.04%436.72M39.24%-25.82M-17.90%-31.25M
Net cash flow
Beginning cash position -15.58%229.66M36.18%239.99M-6.74%176.24M89.93%259.58M127.35%284.8M149.01%272.03M-6.74%176.24M6.97%188.97M-30.19%136.67M-38.99%125.27M
Current changes in cash -536.34%-55.72M-110.79%-10.34M600.54%63.76M-149.50%-19.59M-321.12%-25.22M-20.31%12.77M220.15%95.79M-203.48%-12.74M680.51%39.56M219.66%11.4M
End cash Position -38.92%173.94M-15.58%229.66M36.18%239.99M36.18%239.99M89.93%259.58M127.35%284.8M149.01%272.03M-6.74%176.24M-6.74%176.24M-30.19%136.67M
Free cash flow -32.65%67.13M123.20%61.37M123.71%274.29M11.91%73.17M73.37%73.95M149.23%99.67M208.15%27.5M20.66%122.61M83.24%65.39M151.24%42.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data